• Title/Summary/Keyword: prevention and treatment

Search Result 4,878, Processing Time 0.034 seconds

Application of Pulsed Electric Field Treatment for Scaling Prevention (스케일형성 방지를 위한 펄스 전기장 처리의 적용)

  • Choi, Seung-Pil;Kim, Jong-Oh
    • Journal of the Korean GEO-environmental Society
    • /
    • v.12 no.10
    • /
    • pp.51-56
    • /
    • 2011
  • This study was conducted to investigate the applicability of pulsed electric field (PEF) treatment for the prevention of scaling formation and membrane fouling reduction. To validate the effect of PEF and to identify the mechanism, some experiments with and without PEF treatment were carried out. PEF treatment affected the precipitation of $CaCO_3$ by which $CaCO_3$ particles were actively grown and sedimented. It was confirmed that the calcium ions were decreased as 78% and particle size was grown by PEF treatment. It was also verified that the crystalline structure of $CaCO_3$ was transformed by PEF treatment from Aragonite, which is formed at a high temperature and hard to be removed, to Calcite being stable at room temperature. In PEF treatment, permeate volume and permeation flux were greater than that of without PEF, case while Langelier Index(LI) decreased. From the experiment results, PEF treatment is believed to be an effective method to prevent scaling formation and to mitigate $CaCO_3$ fouling as the pretreatment of membrane filtration.

Effect of Mecadox in Treatment of Colibacillosis and Prevention of Experimental Salmonella Infection in Swine (자돈하리증(仔豚下痢症) 및 Salmonella 인공감염증(人工感染症)에 대한 Mecadox의 치료 및 예방효과)

  • Seo, Ik Soo;Chung, Gill Taik;Han, In Kyu
    • Korean Journal of Veterinary Research
    • /
    • v.15 no.1
    • /
    • pp.119-121
    • /
    • 1975
  • The effect of mecadox, trade name of carbodox, in the treatment of colibacillosis and in the prevention of experimental Salmonella infection in swine was studied throughout the experimental period of four weeks using a total of 70 piglets. The results obtained are as followings. 1. Mecadox was found moderately effective as a therapeutic for colibacillosis of piglets when administered orally as pig doser or added to the feed at the ratio of 50 ppm with or without the addition of vitamin A and $D_3$. 2. In the prevention of experimental infection with Sal. choleraesuis, mecadox was found highly effective. As judged by clinical symptoms such as diarrhea and fever together with the confirmation of excretion of the causative organisms in the feces, the best result was obtained with mecadox pig doser followed by mecadox (50ppm) with vitamin A and $D_3$, and mecadox (50 ppm) without the vitamins in the descending order of effectiveness.

  • PDF

Factors Related to Treatment Refusal in Taiwanese Cancer Patients

  • Chiang, Ting-Yu;Wang, Chao-Hui;Lin, Yu-Fen;Chou, Shu-Lan;Wang, Ching-Ting;Juang, Hsiao-Ting;Lin, Yung-Chang;Lin, Mei-Hsiang
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.8
    • /
    • pp.3153-3157
    • /
    • 2015
  • Background: Incidence and mortality rates for cancer have increased dramatically in the recent 30 years in Taiwan. However, not all patients receive treatment. Treatment refusal might impair patient survival and life quality. In order to improve this situation, we proposed this study to evaluate factors that are related to refusal of treatment in cancer patients via a cancer case manager system. Materials and Methods: This study analysed data from a case management system during the period from 2010 to 2012 at a medical center in Northern Taiwan. We enrolled a total of 14,974 patients who were diagnosed with cancer. Using the PRECEDE Model as a framework, we conducted logistic regression analysis to identify independent variables that are significantly associated with refusal of therapy in cancer patients. A multivariate logistic regression model was also applied to estimate adjusted the odds ratios (ORs) with 95% confidence intervals (95%CI). Results: A total of 253 patients (1.69%) refused treatment. The multivariate logistic regression result showed that the high risk factors for refusal of treatment in cancer patient included: concerns about adverse effects (p<0.001), poor performance(p<0.001), changes in medical condition (p<0.001), timing of case manager contact (p=.026), the methods by which case manager contact patients (p<0.001) and the frequency that case managers contact patients (${\geq}10times$) (p=0.016). Conclusions: Cancer patients who refuse treatment have poor survival. The present study provides evidence of factors that are related to refusal of therapy and might be helpful for further application and improvement of cancer care.

A Study on The Oriental-medical Understanding of Suicide - Within Donguibogam Book - (자살에 대한 한의학적 고찰 - 『동의보감(東醫寶鑑)』을 중심으로)

  • Lee, Ru-Da;Ko, In-Sung;Lee, Sang-Won;Hwang, Seon-Hye;Park, Se-Jin;Kang, Hyung-Won
    • Journal of Oriental Neuropsychiatry
    • /
    • v.26 no.2
    • /
    • pp.171-180
    • /
    • 2015
  • Donguibogam's views on human life provide us with insight into suicide prevention by perceiving life as priceless. In addition to the approaches of modern medicine, we can employ 'mentally and physically integrative treatment' and 'prevention-based treatment' from Korean medicine as a therapeutic point of view. We can also employ 'I-Jeong-Byeon-Gi Therapy' and 'Oh-Ji-Sang-Seung Therapy' as therapeutic methods. In this paper, we consider these approaches and clinical adaptations for suicide prevention from the perspectives of Korean medicine.

Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies

  • Tang, Yu-Long;Qi, Xing-Shun;Guo, Xiao-Zhong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.17
    • /
    • pp.7871-7874
    • /
    • 2015
  • Background: There is no consensus regarding the selection of treatment options for hepatocellular carcinoma (HCC) after initial transarterial chemoembolization (TACE). This meta-analysis aimed to explore the survival benefit of hepatic resection after initial TACE for the treatment of HCC. Materials and Methods: We searched three major databases to identify all relevant papers comparing the outcomes of hepatic resection after initial TACE versus TACE alone for the treatment of HCC. Hazard ratios (HRs) with 95% confidence intervals (95%CIs) were calculated to evaluate the survival benefit of hepatic resection after initial TACE over TACE alone. Results: Three of 2037 initially identified papers were included. All of them were cohort studies from Asia. There was a significantly better overall survival (OS) in patients undergoing hepatic resection after initial TACE than in those undergoing TACE alone (HR=0.63, 95%CI=0.52-0.76, P<0.00001). The heterogeneity among studies was not statistically significant (P=0.96; I2=0%). Conclusions: Hepatic resection could improve the OS of HCC patients treated with initial TACE. Further randomized controlled trials should be necessary to identify the target population for the sequential use of hepatic resection after initial TACE and to compare the outcomes between patients undergoing hepatic resection after initial TACE session versus those undergoing TACE alone.

Breast Cancer: Major Risk Factors and Recent Developments in Treatment

  • Majeed, Wafa;Aslam, Bilal;Javed, Ijaz;Khaliq, Tanweer;Muhammad, Faqir;Ali, Asghar;Raza, Ahmad
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.8
    • /
    • pp.3353-3358
    • /
    • 2014
  • Breast cancer is the most common in women worldwide, with some 5-10% of all cases due to inherited mutations of BRCA1 and BRCA2 genes. Obesity, hormone therapy and use of alcohol are possible causes and over-expression of leptin in adipose tissue may also play a role. Normally surgery, radiation therapy and chemotherapy allow a good prognosis where screening measures are in place. New hope in treatment measures include adjuvant therapy, neoadjuvant therapy, and introduction of mono-clonal antibodies and enzyme inhibitors.

Using Implementation Science to Advance Cancer Prevention in India

  • Krishnan, Suneeta;Sivaram, Sudha;Anderson, Benjamin O.;Basu, Partha;Belinson, Jerome L;Bhatla, Neerja;D' Cruz, Anil;Dhillon, Preet K.;Gupta, Prakash C.;Joshi, Niranjan;Jhulka, PK;Kailash, Uma;Kapambwe, Sharon;Katoch, Vishwa Mohan;Kaur, Prabhdeep;Kaur, Tanvir;Mathur, Prashant;Prakash, Anshu;Sankaranarayanan, R;Selvam, Jerard M;Seth, Tulika;Shah, Keerti V;Shastri, Surendra;Siddiqi, Maqsood;Srivastava, Anurag;Trimble, Edward;Rajaraman, Preetha;Mehrotra, Ravi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.9
    • /
    • pp.3639-3644
    • /
    • 2015
  • Oral, cervical and breast cancers, which are either preventable and/or amenable to early detection and treatment, are the leading causes of cancer-related morbidity and mortality in India. In this paper, we describe implementation science research priorities to catalyze the prevention and control of these cancers in India. Research priorities were organized using a framework based on the implementation science literature and the World Health Organization's definition of health systems. They addressed both community-level as well as health systems-level issues. Community-level or "pull" priorities included the need to identify effective strategies to raise public awareness and understanding of cancer prevention, monitor knowledge levels, and address fear and stigma. Health systems-level or "push" and "infrastructure" priorities included dissemination of evidence-based practices, testing of point-of-care technologies for screening and diagnosis, identification of appropriate service delivery and financing models, and assessment of strategies to enhance the health workforce. Given the extent of available evidence, it is critical that cancer prevention and treatment efforts in India are accelerated. Implementation science research can generate critical insights and evidence to inform this acceleration.

Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma

  • Mansour, Sahar F;Atwa, Maha M
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.17
    • /
    • pp.7491-7496
    • /
    • 2015
  • Background: Biomarkers in breast neoplasms provide invaluable information regarding prognosis and help determining the optimal treatment. We investigated the possible correlation between cancer stem cell (CSC) markers (CD133, and ALDH1) in invasive ductal breast carcinomas with some clinicopathological parameters. Aim: To assess the correlation between expression of cancer stem cell (CSC) markers (CD133, and ALDH1) and clinicopathological parameters of invasive ductal breast carcinomas. Materials and Methods: Immunohistochemical analysis of CD133 and ALDH1 was performed on a series of 120 modified radical mastectomy (MRM) specimens diagnosed as invasive ductal breast carcinoma. Results: Expression of both CD133 and ALDH1 was significantly changed and related to tumor size, tumor stage (TNM), and lymph node metastasis. A negative correlation between CD133 and ALDH1 was found. Conclusions: Detecting the expression of CD133 and ALDH1 in invasive ductal breast carcinomas may be of help in more accurately predicting the aggressive properties and determining the optimal treatment.

Sarcopenia in Cancer Patients

  • Chindapasirt, Jarin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.18
    • /
    • pp.8075-8077
    • /
    • 2016
  • Sarcopenia, characterized by a decline of skeletal muscle plus low muscle strength and/or physical performance, has emerged to be an important prognostic factor for advanced cancer patients. It is associated with poor performance status, toxicity from chemotherapy, and shorter time of tumor control. There is limited data about sarcopenia in cancer patients and associated factors. Moreover, the knowledge about the changes of muscle mass during chemotherapy and its impact to response and toxicity to chemotherapy is still lacking. This review aimed to provide understanding about sarcopenia and to emphasize its importance to cancer treatment.

Importance of Social Support in Cancer Patients

  • Usta, Yasemin Yildirim
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.13 no.8
    • /
    • pp.3569-3572
    • /
    • 2012
  • Social support is regarded as a complex construct which has long been suggested to have direct and buffering effects on patients' wellbeing and emotional adjustment to cancer. Cross-sectional and prospective studies show a positive association between perceived social support and psychological adjustment following cancer treatment. Research findings suggest that the evidence for the relationship between social support and cancer progression is sufficiently strong. This report points out the importance of social support in cancer and provides recommendations for health care professionals.